Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
Abstract Introduction Similar outcomes have been observed between patients with rheumatoid arthritis (RA) responding to tocilizumab (TCZ) with methotrexate (MTX) who discontinued vs. continued MTX and between patients receiving MTX who added TCZ vs. switched to TCZ monotherapy. This study examined M...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Adis, Springer Healthcare
2020-03-01
|
| Col·lecció: | Rheumatology and Therapy |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s40744-020-00200-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|